PISCATAWAY, New Jersey--Milestone Scientific, a leader in advanced injection technologies, has announced that Leslie Bernhard, an independent director, has been named chairman of the Board.
Bernhard will succeed Leonard Osser, who had previously led the company as chairman since 1991. Osser, who has also served as the interim chief executive officer since February 2009 and was formerly Milestone's CEO from 1991 through 2007, will again lead the company as its CEO, effective immediately.
"In view of Leonard's passion, vision and well-defined strategy for optimizing Milestone's future growth, having him resume the full duties and responsibilities of the CEO post is without question in the best interests of the company, its dedicated workforce and its shareholders," stated Bernhard.
"Moreover, by my assuming the chairmanship, the Board can take advantage of enhancing our corporate governance and oversight, while freeing Leonard to concentrate on achieving the company's mission critical goals and objectives."
Commenting on the leadership changes, Osser noted, "We are now seeing a number of promising growth opportunities in the international markets related to the expansion of our global dental distribution network and worldwide marketing of our award winning STA Single Tooth Anesthesia System. We are also gaining meaningful traction in our negotiations in collaborating on the development of new medical products utilizing our patented CompuFlo technology.
"Consequently, the Board determined that my time and effort was best utilized focused on fully capitalizing on these promising opportunities. As such, I'm very pleased that Leslie has agreed to assume leadership of the Board. In my capacity as a director and CEO, I look forward to working closely with her to help guide and manage our company's long term growth and anticipated success," added Osser.
To read more about Milestone Scientific, go to Milestone Scientific.
To comment on this topic, go to PennWell Dental Community site.